Achieve Life Sciences, Inc. ACHV
ACHV
Achieve Life Sciences, Inc. TRDA
Entrada Therapeutics, Inc. VNDA
Vanda Pharmaceuticals Inc. HUMA
Humacyte, Inc. VYGR
Voyager Therapeutics, Inc. AVIR
Atea Pharmaceuticals, Inc. ARCT
Arcturus Therapeutics Holdings Inc. ALLO
Allogene Therapeutics, Inc. CAPR
Capricor Therapeutics, Inc. SGMT
Sagimet Biosciences Inc.
Achieve Life Sciences, Inc. TRDA
Entrada Therapeutics, Inc. VNDA
Vanda Pharmaceuticals Inc. HUMA
Humacyte, Inc. VYGR
Voyager Therapeutics, Inc. AVIR
Atea Pharmaceuticals, Inc. ARCT
Arcturus Therapeutics Holdings Inc. ALLO
Allogene Therapeutics, Inc. CAPR
Capricor Therapeutics, Inc. SGMT
Sagimet Biosciences Inc.
Performance
| Periode | ACHV | TRDA | VNDA | HUMA | VYGR | AVIR | ARCT | ALLO | CAPR | SGMT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 41.95 % | 55.62 % | 51.89 % | -54.08 % | 36.54 % | -0.93 % | -46.91 % | 9.23 % | 114.52 % | -8.87 % |
| YTD | 14.63 % | -35.74 % | 41.49 % | -79.34 % | -28.64 % | -7.02 % | -61.80 % | -35.45 % | 74.80 % | 39.64 % |
| 1Y | 1.68 % | -39.19 % | 44.19 % | -71.84 % | -31.84 % | 0.63 % | -58.55 % | -31.40 % | 98.11 % | 5.56 % |
| 3Y | 66.54 % | -43.59 % | -5.41 % | -51.58 % | -26.68 % | -27.40 % | -61.10 % | -78.15 % | 660.17 % | -60.69 % |
| 5Y | -44.49 % | -53.15 % | -48.68 % | -89.22 % | -50.06 % | -89.79 % | -93.71 % | -94.78 % | 519.67 % | -60.69 % |
| 10Y | -99.84 % | -53.15 % | -27.29 % | -88.93 % | -79.41 % | -89.52 % | -84.05 % | -94.32 % | -24.42 % | -60.69 % |
| From the beginning | -100.00 % | -53.15 % | -29.55 % | -88.93 % | -76.00 % | -89.52 % | -87.66 % | -94.32 % | -94.19 % | -60.69 % |